EUVIMEDEUVIMED entdecken
Crossref

The Latest Advances in Peptide Receptor Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine Tumors

Elif Hindié, Eric Baudin, Rodney J Hicks, David Taïeb

Journal of Nuclear Medicine · 2023

DOI: 10.2967/jnumed.122.264422 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2023. Verfasst von Elif Hindié und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, CHU de Bordeaux, University of Bordeaux, Bordeaux, France; elif.hindie@chu-bordeaux.fr. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Pancreatic Neoplasms, Stomach Neoplasms, Intestinal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We would like to draw attention to the latest advances in the field of peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors (NETs) of gastroenteropancreatic origin. The term NET refers to well-differentiated tumors that can be grade 1 (Ki-67 index,

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsPancreatic NeoplasmsStomach NeoplasmsIntestinal NeoplasmsHumansRadioisotopesReceptors, Peptide

Substanzen

RadioisotopesReceptors, Peptide

Autor:innen und Institutionen

  • Department of Nuclear Medicine, CHU de Bordeaux, University of Bordeaux, Bordeaux, France; elif.hindie@chu-bordeaux.fr.
  • Department of Endocrine Oncology and Imaging, Gustave Roussy Cancer Campus, Villejuif, France.
  • Department of Medicine, St. Vincent's Hospital Medical School, University of Melbourne, Melbourne, Victoria, Australia; and.
  • Department of Nuclear Medicine, La Timone Hospital, Aix-Marseille University, Marseille, France.

Zitieren

APA

Hindié, E., Baudin, E., Hicks, R. J., & Taïeb, D. (2023). The Latest Advances in Peptide Receptor Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine Tumors. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.122.264422

Vancouver

Hindié E, Baudin E, Hicks RJ, Taïeb D. The Latest Advances in Peptide Receptor Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine Tumors. Journal of Nuclear Medicine. 2023. doi:10.2967/jnumed.122.264422

BibTeX
@article{Hindi2023,
  author = {Hindié, Elif and Baudin, Eric and Hicks, Rodney J and Taïeb, David},
  title = {The Latest Advances in Peptide Receptor Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine Tumors},
  journal = {Journal of Nuclear Medicine},
  year = {2023},
  doi = {10.2967/jnumed.122.264422}
}
Kostenlos starten →